Cargando…
Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
Objective: Pirarubicin (THP), one of the anthracycline anticancer drugs, is widely used in the treatment of various cancers, but its cardiotoxicity cannot be ignored. Schisandrin B (SchB) has the ability to upregulate cellular antioxidant defense mechanism and promote mitochondrial function and anti...
Autores principales: | Shi, Hongwei, Tang, Heng, Ai, Wen, Zeng, Qingfu, Yang, Hong, Zhu, Fengqing, Wei, Yunjie, Feng, Rui, Wen, Li, Pu, Peng, He, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554014/ https://www.ncbi.nlm.nih.gov/pubmed/34721023 http://dx.doi.org/10.3389/fphar.2021.733805 |
Ejemplares similares
-
Corrigendum: Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis
por: Shi, Hongwei, et al.
Publicado: (2021) -
Reducing oxidative stress may be important for treating pirarubicin-induced cardiotoxicity with schisandrin B
por: Tang, Heng, et al.
Publicado: (2022) -
Schisandrin B Diet Inhibits Oxidative Stress to Reduce Ferroptosis and Lipid Peroxidation to Prevent Pirarubicin-Induced Hepatotoxicity
por: Shi, Hongwei, et al.
Publicado: (2022) -
Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid
por: Teixeira, José, et al.
Publicado: (2018) -
Calcium Elevation in Mitochondria Is the Main Ca(2+) Requirement for Mitochondrial Permeability Transition Pore (mPTP) Opening
por: Baumgartner, Heidi K., et al.
Publicado: (2009)